上集講述了PD1/PDL1在醫治癌細胞免疫治療方面的重要性,接下來我們將會繼續深入探討問題。257Please respect copyright.PENANAQXjXd53YxG
257Please respect copyright.PENANA1TGhACWzd1
上集:https://www.penana.com/article/471125257Please respect copyright.PENANAZpgpbVwnOw
257Please respect copyright.PENANAKx4fYGYbHt257Please respect copyright.PENANABiUx9wAXqA
257Please respect copyright.PENANAP6eCfwJ7jU
(圖1)雖然阻擋PD1/PDL1可以增強T cell辨認癌細胞的能力,但另一個重要的問題是,如何確保有足夠的T cell殺滅癌細胞呢?257Please respect copyright.PENANA6ve0EfPVy4
257Please respect copyright.PENANAWsR9YFMe1E
就算成功糾正免疫系統細胞懂得把癌細胞辨認為外來之物,但免疫系統細胞數量不足的話,依然是不會達到重大效果的。257Please respect copyright.PENANAbg5Hlu6en3
257Please respect copyright.PENANAa8Ph7n1YZ9
換句話說,我們需要一道能夠提升針對癌細胞的T cell數量手段。257Please respect copyright.PENANANKC3wbO4sJ
257Please respect copyright.PENANA27aRzkgT0M257Please respect copyright.PENANA33bbmGv0xK
257Please respect copyright.PENANAcZOasM79CI
(圖2)T cell的產生數量,接近可以說是由Antigen Presenting Cells(APC)來決定;257Please respect copyright.PENANALbvMbe5VYa
APC可以睇成為一堆負責把癌細胞獨特Neoantigen帶來T cell面前的細胞。257Please respect copyright.PENANAMFSwo2YBTh
257Please respect copyright.PENANAD1d3v9AWBd
忘記甚麼是Neoantigen的話,可重溫上一集。257Please respect copyright.PENANAJRcTETlKzs
257Please respect copyright.PENANAPstpvyYi5Q
當APC展示癌細胞的Neoantigen予T cell的receptor後,另一個必需的動作就是T cell表面的CD28與APC表面的B7合併。257Please respect copyright.PENANAAWsC3vXqBV
257Please respect copyright.PENANAZp9jYIFXek
只要兩者條件達成的話,負責對付對應癌細胞的T cell數量及效力便會大增。257Please respect copyright.PENANAnYrkcWvI6Z
257Please respect copyright.PENANAIzL1d0dtB4257Please respect copyright.PENANAQjJa7va0z8
257Please respect copyright.PENANAhseNskeJjQ
(圖3)然而,當T cell數量產生至一定程度的時候,T cell便會產生出CTLA4。CTLA4會搶奪CD28的位置,與B7合併。257Please respect copyright.PENANA5EvaXzjPza
257Please respect copyright.PENANAA4eHl0fOhr
而當CTLA4與B7合併後,T cell所產生的數量及威力就會大減。257Please respect copyright.PENANAr6AZt0kmzc
257Please respect copyright.PENANAhcx3fMLe8m
這個CTLA4產生的機制是與生俱來的,目的就是為了避免產生過量的T cell,以免身體會產生不良反應。257Please respect copyright.PENANAdP37RpPrtK257Please respect copyright.PENANA6YZiU5bgwv
257Please respect copyright.PENANAPd1Xvdm8UU
(圖4)只不過的是,現時癌細胞大敵當前,燃眉之急就是要調動大量的T cell前往討伐癌細胞。257Please respect copyright.PENANAeQIlUKORZM
257Please respect copyright.PENANAQTxpveRfDU
為此,我們重施應對PD1/PDL1故技,利用抗體阻擋CTLA4,確保CD28及B7持續合併,不斷產生效力高強的T cell。257Please respect copyright.PENANAw0vZFkxxeS257Please respect copyright.PENANA4nXys1clyp
257Please respect copyright.PENANA2MqvKgPXp2
(圖5)簡略的總結來說,為了確保有足夠的T cell消滅癌細胞,我們不惜採用阻擋CTLA4的抗體,號令身體持續產生效力高強的T cell。257Please respect copyright.PENANA8HaStNf983
而另一邊廂,我們亦同時利用阻擋PD1/PDL1的抗體,確保T cell能夠順利把癌細胞辨認成為外來物,將其制裁。257Please respect copyright.PENANA2xthWwgwmf
257Please respect copyright.PENANA9TOpQk6Uma
這CTLA4抗體及PD1/PDL1抗體的雙管齊下療法,將能大大提升免疫治療的效率。257Please respect copyright.PENANAv7dzNMHAt5
257Please respect copyright.PENANAw5a2gVOh1z
但是,並不是所有病人也能依靠這方法而得益,原因是T cell沒法能夠順利抵達癌細胞的位置以及滲入癌細胞的內部作有效的消滅。257Please respect copyright.PENANAJS7E9eKPEg
257Please respect copyright.PENANAyBcdLE4pI6
這一方面,我們將會在下一篇免疫治療的最終章再作探討。257Please respect copyright.PENANAwTUDqf8Zlu
257Please respect copyright.PENANAgzQaVfEVTh
257Please respect copyright.PENANAo79u4Q1ekC
如果想我快啲出文的話,請入去Penana網站科普專欄–薯不揀單俾一個like以及Bookmark,這對我非常之重要。257Please respect copyright.PENANApien8RFqlc
257Please respect copyright.PENANAq6lmRrpgO8
Link: https://www.penana.com/story/66244/%E7%A7%91%E6%99%AE%E5%B0%88%E6%AC%84-%E8%96%AF%E4%B8%8D%E6%8F%80%E5%96%AE/toc257Please respect copyright.PENANAbx3zjlQ7x0
257Please respect copyright.PENANAc24es9pjat
同時亦可以在Penana網站裡按「買一嚿/半嚿薯仔」,以課金的方式推動我繼續搜羅資料寫文,多謝。257Please respect copyright.PENANAXQMyMqDOlp
257Please respect copyright.PENANA6HHE2BZ3oW
Link:257Please respect copyright.PENANA8DtNtLo986
https://www.penana.com/user/27349/%E8%96%AF%E4%BB%94%E8%81%9E%E8%8C%B1%E8%8E%89/portfolio257Please respect copyright.PENANAEnxH0DmIwq
257Please respect copyright.PENANAFF2LUk561b
257Please respect copyright.PENANAjYWmgdFVFB
有興趣接收科普資訊的話,歡迎follow IG: potatopigtongue。257Please respect copyright.PENANA4PTacVlNVM
copyright protection253PENANAh5KSr9Ndqf
科普專欄–薯不揀單
Tags
- G: General Audiences
- PG: Parental Guidance Suggested
- PG-13: Parents Strongly Cautioned
- R: Restricted
RATED

Popularity
Follow Author
#31
深入淺出–以免疫治療(Immunotherapy)手段醫治癌細胞(二)
Comments ( 0 )
No comments yet. Be the first!
Loading...